95-29414. Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Patent Application Concerning Encapsulated High- Concentration Lipid A Composition as Immunogenic Agents

[Federal Register Volume 60, Number 232 (Monday, December 4, 1995)]
[Notices]
[Page 62083]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-29414]



-----------------------------------------------------------------------


DEPARTMENT OF DEFENSE

Availability for Non-Exclusive, Exclusive, or Partially Exclusive 
Licensing of U.S. Patent Application Concerning Encapsulated High-
Concentration Lipid A Composition as Immunogenic Agents

AGENCY: U.S. Army Medical Research and Materiel Command, DOD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with 37 CFR 404.6, announcement is made of the 
availability of U.S. Patent Application Serial No. 07/601,090 filed 
October 22, 1990 and entitled ``Encapsulated High-Concentration Lipid A 
Compositions as Immunogenic Agents to Produce Human Antibodies to 
Prevent or Treat Gram-Negative Bacterial Infections''. This Notice also 
announces the withdrawal of the intent to grant exclusive patent 
license to Univax Biologics, Inc. as indicated in the Federal Register, 
Volume 57, Number 99, page 21648 (May 21, 1992). This patent has been 
assigned to the United States Government as represented by the 
Secretary of the Army.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Staff Judge Advocate, Fort Detrick, Frederick, Maryland 21702-
5012.

FOR FURTHER INFORMATION CONTACT:
Mr. John F. Moran, Patent Attorney, [phone] or telefax (301) 
619-7714.

SUPPLEMENTARY INFORMATION: This invention is directed to the production 
of antibodies against lipid A by using encapsulating slow-releasing 
delivery materials or devices containing concentrations of lipid A that 
are greater than could be given safely to humans in the absence of said 
materials or devices. The antibodies to lipid A can be used for binding 
the antibodies to the lipid A that is present in the lipopolysaccharide 
that coats the surface of the Gram-negative bacteria.
Gregory D. Showalter,
Army Federal Register Liaison Officer.
[FR Doc. 95-29414 Filed 12-1-95; 8:45 am]
BILLING CODE 3710-08-M